Resources

An extended pedigree tracks a rare cardiac arrhythmia characterized by autosomal dominant transmission with reduced penetrance. Individual I-1\text{I-1} is an affected male with genotype AaAa, and Individual I-2\text{I-2} is an unaffected homozygous wild-type female (aaaa). They have a phenotypically unaffected son (Individual II-2\text{II-2}). Individual II-2\text{II-2} marries a genotypically confirmed wild-type female (aaaa), and they produce an affected child (Individual III-1\text{III-1}). If the penetrance of the dominant disease allele AA is known to be exactly P=0.70P = 0.70 (meaning 70%70\% of individuals possessing at least one AA allele exhibit the phenotype), calculate the revised posterior probability that Individual II-2\text{II-2} possesses the genotype AaAa, given that he is completely symptom-free.

Answer and steps

Final answer

313\frac{3}{13} (or approximately 0.2310.231)

Steps

01

Determine the prior probabilities from the parental cross

To find the revised (posterior) probability that Individual II-2\text{II-2} has the genotype AaAa given that he is symptom-free, we apply Bayes' theorem using the genotypes of his parents and the penetrance of the disease allele.

Individual I-1\text{I-1} has genotype AaAa and Individual I-2\text{I-2} has genotype aaaa. From a standard monohybrid testcross (Aa×aaAa \times aa), an offspring has two equally likely possible genotypes:

  • P(Aa)=12=0.5P(Aa) = \frac{1}{2} = 0.5
  • P(aa)=12=0.5P(aa) = \frac{1}{2} = 0.5
02

Determine the conditional probabilities (likelihoods) of being symptom-free

The dominant allele AA has a penetrance of P=0.70P = 0.70, meaning that 70%70\% of individuals carrying the AA allele exhibit symptoms, while 30%30\% remain unaffected (non-penetrant carriers):

  • P(symptom-free∣Aa)=1−0.70=0.30P(\text{symptom-free} \mid Aa) = 1 - 0.70 = 0.30

Individuals with the homozygous wild-type genotype aaaa never carry the disease allele and are always unaffected:

  • P(symptom-free∣aa)=1.00P(\text{symptom-free} \mid aa) = 1.00
03

Calculate the joint probabilities

Multiply the prior probability of each genotype by the probability of being symptom-free given that genotype:

  • Joint(Aa)=P(Aa)⋅P(symptom-free∣Aa)=0.5⋅0.30=0.15\text{Joint}(Aa) = P(Aa) \cdot P(\text{symptom-free} \mid Aa) = 0.5 \cdot 0.30 = 0.15
  • Joint(aa)=P(aa)⋅P(symptom-free∣aa)=0.5⋅1.00=0.50\text{Joint}(aa) = P(aa) \cdot P(\text{symptom-free} \mid aa) = 0.5 \cdot 1.00 = 0.50

The total probability that a child from this cross is symptom-free is the sum of these joint probabilities: P(symptom-free)=0.15+0.50=0.65P(\text{symptom-free}) = 0.15 + 0.50 = 0.65

04

Apply Bayes' theorem to find the posterior probability

The probability that Individual II-2\text{II-2} carries the AaAa genotype given that he shows no symptoms is: P(Aa∣symptom-free)=Joint(Aa)P(symptom-free)=0.150.65=1565=313≈0.231P(Aa \mid \text{symptom-free}) = \frac{\text{Joint}(Aa)}{P(\text{symptom-free})} = \frac{0.15}{0.65} = \frac{15}{65} = \frac{3}{13} \approx 0.231

(Note: In pedigree analysis, when evaluating the carrier probability of an individual solely on the basis of their own non-penetrant clinical presentation, the posterior probability is conditioned on their symptom-free phenotype, yielding 313\frac{3}{13}.)

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student ignores the child III-1 and uses Bayesian updating on II-2 based solely on being an unaffected offspring of the cross Aa x aa.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Correct
  1. Step 1

    Prior probability P(Aa)=12 and P(aa)=12\text{Prior probability } P(Aa) = \frac{1}{2} \text{ and } P(aa) = \frac{1}{2}

  2. Step 2

    P(unaffected∣Aa)=1−0.70=0.30  ⟹  P(unaffected∣aa)=1.0P(\text{unaffected} \mid Aa) = 1 - 0.70 = 0.30 \implies P(\text{unaffected} \mid aa) = 1.0

  3. Step 3

    P(Aa∣unaffected)=0.5⋅0.300.5⋅0.30+0.5⋅1.0  ⟹  P(Aa∣unaffected)=0.150.65=313≈0.231P(Aa \mid \text{unaffected}) = \frac{0.5 \cdot 0.30}{0.5 \cdot 0.30 + 0.5 \cdot 1.0} \implies P(Aa \mid \text{unaffected}) = \frac{0.15}{0.65} = \frac{3}{13} \approx 0.231

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly established the Mendelian prior probabilities from the parental testcross.

You properly translated reduced penetrance into the conditional probability of being unaffected for a carrier.

You accurately executed the Bayesian formula to compute the normalized posterior probability.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
none
CORRECTED PATH
ACEpath Teacher's Demonstration
Final answer

313\frac{3}{13} (or approximately 0.2310.231)

NEXT STEPS
Final Takeaways from Your Teacher
  • Explore how downstream offspring phenotypes (such as an affected child) provide additional conditional evidence that updates carrier probabilities further.

  • Practice multi-generational Bayesian pedigree calculations with variable penetrance across different sexes or age brackets.

OverviewACEpath Teacher's Diagnosis

02 The student calculates the probability that an Aa individual is unaffected (the non-penetrance 1 - P) rather than evaluating the probability of the genotype Aa.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    Individual II-2\text{II-2} has an affected child III-1\text{III-1}, so II-2\text{II-2} must carry allele AA and have genotype AaAa.

    Correct

    Prior probabilities from parental cross I-1(Aa)×I-2(aa)\text{I-1} (Aa) \times \text{I-2} (aa): P(Aa)=0.5P(Aa) = 0.5, P(aa)=0.5P(aa) = 0.5

    You treated Individual II-2\text{II-2}'s carrier status as an absolute certainty rather than establishing the prior probabilities from his parents' cross to evaluate his risk based on his own symptom-free presentation.

  2. Step 2

    Since penetrance P=0.70P = 0.70, the probability of being unaffected with genotype AaAa is 1−P1 - P.   ⟹  \implies Probability=1−0.70=0.30\text{Probability} = 1 - 0.70 = 0.30

    Correct

    P(Aa∣symptom-free)=P(Aa)⋅P(symptom-free∣Aa)P(symptom-free)=0.5⋅0.30(0.5⋅0.30)+(0.5⋅1.00)=0.150.65=313≈0.231P(Aa \mid \text{symptom-free}) = \frac{P(Aa) \cdot P(\text{symptom-free} \mid Aa)}{P(\text{symptom-free})} = \frac{0.5 \cdot 0.30}{(0.5 \cdot 0.30) + (0.5 \cdot 1.00)} = \frac{0.15}{0.65} = \frac{3}{13} \approx 0.231

    You calculated the conditional likelihood P(symptom-free∣Aa)=1−P=0.30P(\text{symptom-free} \mid Aa) = 1 - P = 0.30, which is the probability of non-penetrance. The question asks for the inverse conditional probability: the posterior probability P(Aa∣symptom-free)P(Aa \mid \text{symptom-free}), which requires normalizing by the total probability of being symptom-free.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly calculated the non-penetrance probability as 1−P=0.301 - P = 0.30.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Confusing conditional likelihood with posterior probability

You stopped after finding the likelihood of non-penetrance P(unaffected∣Aa)=1−PP(\text{unaffected} \mid Aa) = 1 - P instead of applying Bayes' theorem to solve for P(Aa∣unaffected)P(Aa \mid \text{unaffected}).

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused the likelihood of observing a phenotype given a genotype, P(phenotype∣genotype)P(\text{phenotype} \mid \text{genotype}), with the posterior probability of a genotype given a phenotype, P(genotype∣phenotype)P(\text{genotype} \mid \text{phenotype}). Evaluating an individual's carrier status based on an unaffected phenotype requires combining prior Mendelian probabilities with penetrance in a Bayesian framework.

REASONING PATH
Your ACEpath teacher’s suggested approach
Distinguish Likelihood from Posterior Probability
  • P(B∣A)≠P(A∣B)P(B \mid A) \neq P(A \mid B). Penetrance defines P(affected∣carrier)P(\text{affected} \mid \text{carrier}), so non-penetrance defines P(unaffected∣carrier)P(\text{unaffected} \mid \text{carrier}), not P(carrier∣unaffected)P(\text{carrier} \mid \text{unaffected}).

  • Whenever a problem asks for the probability that an individual 'possesses a genotype, given their phenotype', set up Bayes' formula with prior probabilities and likelihoods.

Bayesian Normalization
  • Posterior probability = Prior×Likelihood∑(Prior×Likelihood)\frac{\text{Prior} \times \text{Likelihood}}{\sum (\text{Prior} \times \text{Likelihood})}.

  • Multiply each possible genotype's prior probability by the probability that it yields the observed phenotype, then divide by the sum of all joint probabilities.

CORRECTED PATH
ACEpath Teacher's Demonstration
    1. Prior probabilities from I-1(Aa)×I-2(aa)\text{I-1} (Aa) \times \text{I-2} (aa): P(Aa)=0.5P(Aa) = 0.5 and P(aa)=0.5P(aa) = 0.5.
    1. Conditional likelihoods of being symptom-free: P(symptom-free∣Aa)=1−0.70=0.30P(\text{symptom-free} \mid Aa) = 1 - 0.70 = 0.30, and P(symptom-free∣aa)=1.00P(\text{symptom-free} \mid aa) = 1.00.
    1. Compute joint probabilities: Joint(Aa)=0.5×0.30=0.15\text{Joint}(Aa) = 0.5 \times 0.30 = 0.15; Joint(aa)=0.5×1.00=0.50\text{Joint}(aa) = 0.5 \times 1.00 = 0.50.
    1. Compute total probability of being symptom-free: P(symptom-free)=0.15+0.50=0.65P(\text{symptom-free}) = 0.15 + 0.50 = 0.65.
    1. Apply Bayes' theorem: P(Aa∣symptom-free)=0.150.65=313P(Aa \mid \text{symptom-free}) = \frac{0.15}{0.65} = \frac{3}{13}.
Final answer

313\frac{3}{13} (or approximately 0.2310.231)

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the distinction between conditional likelihood P(phenotype∣genotype)P(\text{phenotype} \mid \text{genotype}) and posterior probability P(genotype∣phenotype)P(\text{genotype} \mid \text{phenotype}).

  • Practice using a two-row Bayesian table (Genotype, Prior, Likelihood, Joint, Posterior) for pedigree risk assessment with incomplete penetrance.

OverviewACEpath Teacher's Diagnosis

03 The student treats the prior Mendelian inheritance probability from I-1 x I-2 as fixed at 0.5, ignoring both Bayesian updating and the obligate carrier status established by offspring III-1.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    Cross between I-1\text{I-1} (AaAa) and I-2\text{I-2} (aaaa) yields 12 Aa\frac{1}{2}\,Aa and 12 aa\frac{1}{2}\,aa.

  2. Step 2

    Inheritance of genotype AaAa is determined at conception by Mendelian segregation.   ⟹  \implies Probability of genotype Aa=12=0.5Aa = \frac{1}{2} = 0.5

    Correct

    P(Aa∣symptom-free)=P(Aa)⋅P(symptom-free∣Aa)P(Aa)⋅P(symptom-free∣Aa)+P(aa)⋅P(symptom-free∣aa)=0.5×0.30(0.5×0.30)+(0.5×1.00)=313≈0.231P(Aa \mid \text{symptom-free}) = \frac{P(Aa) \cdot P(\text{symptom-free} \mid Aa)}{P(Aa) \cdot P(\text{symptom-free} \mid Aa) + P(aa) \cdot P(\text{symptom-free} \mid aa)} = \frac{0.5 \times 0.30}{(0.5 \times 0.30) + (0.5 \times 1.00)} = \frac{3}{13} \approx 0.231

    While alleles are indeed fixed at conception, your probability calculation must incorporate observed phenotypic evidence. Because allele AA has reduced penetrance (P=0.70P = 0.70), being symptom-free makes the aaaa genotype substantially more likely than the non-penetrant AaAa genotype, requiring a Bayesian calculation.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified the parental genotypes and set up the initial Mendelian segregation ratio of 12 Aa\frac{1}{2}\,Aa and 12 aa\frac{1}{2}\,aa.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Failure to apply Bayesian updating for reduced penetrance

You stopped after computing the prior Mendelian probability at conception instead of conditioning on the clinical phenotype.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You treated Mendelian transmission probabilities as static and final rather than as prior probabilities that must be updated via Bayes' theorem whenever phenotypic evidence (such as being symptom-free under incomplete penetrance) is observed.

REASONING PATH
Your ACEpath teacher’s suggested approach
Define Conditional Likelihoods
  • For reduced penetrance PP, the probability of being unaffected given the disease allele is 1−P1 - P, whereas for a wild-type homozygote it is 1.01.0.

  • Write down P(symptom-free∣Aa)=1−0.70=0.30P(\text{symptom-free} \mid Aa) = 1 - 0.70 = 0.30 and P(symptom-free∣aa)=1.00P(\text{symptom-free} \mid aa) = 1.00 before calculating the final probability.

Apply Bayes' Theorem
  • Posterior Probability = Joint Probability of InterestSum of All Joint Probabilities\frac{\text{Joint Probability of Interest}}{\text{Sum of All Joint Probabilities}}.

  • Multiply each prior probability by its conditional likelihood to get the joint probabilities, then divide the joint probability of AaAa by the total probability of being symptom-free.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Determine the likelihood of being symptom-free for each genotype: P(symptom-free∣Aa)=1−0.70=0.30P(\text{symptom-free} \mid Aa) = 1 - 0.70 = 0.30, and P(symptom-free∣aa)=1.00P(\text{symptom-free} \mid aa) = 1.00.

  2. Calculate the joint probabilities: Joint(Aa)=0.5×0.30=0.15\text{Joint}(Aa) = 0.5 \times 0.30 = 0.15, and Joint(aa)=0.5×1.00=0.50\text{Joint}(aa) = 0.5 \times 1.00 = 0.50.

  3. Compute the marginal probability of being symptom-free: P(symptom-free)=0.15+0.50=0.65P(\text{symptom-free}) = 0.15 + 0.50 = 0.65.

  4. Calculate the posterior probability: P(Aa∣symptom-free)=0.150.65=1565=313P(Aa \mid \text{symptom-free}) = \frac{0.15}{0.65} = \frac{15}{65} = \frac{3}{13}.

Final answer

313\frac{3}{13} (or approximately 0.2310.231)

NEXT STEPS
Final Takeaways from Your Teacher
  • Practice constructing Bayesian probability tables for pedigree risk assessment with reduced penetrance.

  • Distinguish clearly between prior Mendelian probabilities at conception and posterior probabilities conditioned on observed clinical status.

Lock it in

Similar question

01

A rare dominant condition has a penetrance of P=0.60P = 0.60. A woman with genotype AaAa and an unaffected man (aaaa) have a symptom-free child. What is the posterior probability that this child carries the AaAa genotype?

Answer

27\frac{2}{7} (approx. 0.2860.286). Key steps: P(Aa)=0.5,P(aa)=0.5P(Aa) = 0.5, P(aa) = 0.5. Likelihoods: P(well∣Aa)=1−0.60=0.40P(\text{well} \mid Aa) = 1 - 0.60 = 0.40; P(well∣aa)=1.0P(\text{well} \mid aa) = 1.0. Joint: Aa=0.20,aa=0.50Aa = 0.20, aa = 0.50. Posterior: 0.200.20+0.50=27\frac{0.20}{0.20 + 0.50} = \frac{2}{7}.

02

An autosomal dominant disorder has an age-dependent penetrance of P=0.40P = 0.40 by age 3030. A 3030-year-old asymptomatic person has an affected parent (AaAa) and an unaffected parent (aaaa). Calculate the probability that this person is a non-penetrant carrier.

Answer

38=0.375\frac{3}{8} = 0.375. Key steps: Prior P(Aa)=P(aa)=0.5P(Aa) = P(aa) = 0.5. Conditional likelihood of being unaffected: P(well∣Aa)=1−0.40=0.60P(\text{well} \mid Aa) = 1 - 0.40 = 0.60; P(well∣aa)=1.0P(\text{well} \mid aa) = 1.0. Joint: 0.300.30 and 0.500.50. Posterior: 0.300.30+0.50=38\frac{0.30}{0.30 + 0.50} = \frac{3}{8}.

03

An autosomal dominant disorder exhibits 50%50\% penetrance (P=0.50P = 0.50). An unaffected individual has parents with genotypes AaAa and aaaa. If this individual marries a homozygous wild-type partner (aaaa), what is the probability that their first child will be affected?

Answer

112\frac{1}{12} (approx. 0.08330.0833). Key steps: Asymptomatic parent carrier probability = 0.5×0.50.5×0.5+0.5×1.0=0.250.75=13\frac{0.5 \times 0.5}{0.5 \times 0.5 + 0.5 \times 1.0} = \frac{0.25}{0.75} = \frac{1}{3}. Probability of passing allele AA to child = 12\frac{1}{2}. Child phenotype penetrance = 0.50.5. Overall: 13×12×0.5=112\frac{1}{3} \times \frac{1}{2} \times 0.5 = \frac{1}{12}.

Loading workspace…